Artificial Intelligence (AI) can help develop a customised vaccine against cancer for an individual in just 48 hours, said ...

Oracle Chairman Larry Ellison ... According to Ellison, AI could revolutionize cancer detection, treatment, and vaccine development, offering groundbreaking capabilities. Ellison explained that ...

A key early innovator in that race is Everest Medicines Ltd. (1952.HK), China's leading biopharma company to integrate AI into mRNA cancer vaccine research. The company is advancing its AI-powered ...

Designed with Evaxion’s AI-Immunology™ platform, EVX-01 is a personalized cancer vaccine currently being evaluated as a treatment for advanced melanoma (skin cancer). Evaxion will present new ...

Oracle co-founder Larry Ellison recently highlighted the promise of cancer vaccines in a discussion at the White House, further amplifying public awareness of progress in the field. “We all know ...

Anixa Biosciences (ANIX) has entered into a letter of intent with Verdi Solutions to develop personalized and off-the-shelf peptide vaccines ...

Anixa Biosciences secured a six-month exclusive right to negotiate a deal for VERDI's cancer vaccines. VERDI’s AI-driven platform develops personalized and off-the-shelf peptide vaccines for ...

On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to Anixa Biosciences, Inc.'s (NASDAQ:ANIX) breast cancer vaccine technology.

New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer ... groundbreaking AI-Immunology platform and vaccine pipeline ...